Ensign Peak Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.82M | Hold |
|
|||||
|
2025
Q1 | $6.04M | Sell |
|
|||||
|
2024
Q4 | $9.04M | Sell |
|
|||||
|
2024
Q3 | $8.6M | Sell |
|
|||||
|
2024
Q2 | $7.61M | Hold |
|
|||||
|
2024
Q1 | $5.59M | Hold |
|
|||||
|
2023
Q4 | $6.57M | Hold |
|
|||||
|
2023
Q3 | $7.03M | Sell |
|
|||||
|
2023
Q2 | $5.84M | Hold |
|
|||||
|
2023
Q1 | $5.42M | Hold |
|
|||||
|
2022
Q4 | $4.4M | Sell |
|
|||||
|
2022
Q3 | $4.85M | Buy |
|
|||||
|
2022
Q2 | $3.06M | Buy |
|
|||||
|
2022
Q1 | $2.78M | Hold |
|
|||||
|
2021
Q4 | $2.02M | Hold |
|
|||||
|
2021
Q3 | $2.52M | Hold |
|
|||||
|
2021
Q2 | $2.19M | Hold |
|
|||||
|
2021
Q1 | $2.5M | Hold |
|
|||||
|
2020
Q4 | $2.21M | Buy |
|
|||||
|
2020
Q3 | $509K | Buy |
|
|||||
|
2020
Q2 | $36K | Hold |
|
|||||
|
2020
Q1 | $26K | Sell |
|
|||||
|
2019
Q4 | $116K | Buy |
|